Generation Bio Co (GBIO)vsRevolution Medicines Inc (RVMD)
GBIO
Generation Bio Co
$5.34
0.00%
HEALTHCARE · Cap: $35.98M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Generation Bio Co generates 1958% more annual revenue ($15.27M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. GBIO earns a higher WallStSmart Score of 32/100 (F).
GBIO
Avoid32
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -0.8% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : GBIO
The strongest argument for GBIO centers on Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : GBIO
The primary concerns for GBIO are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
GBIO carries more volatility with a beta of 2.01 — expect wider price swings.
GBIO is growing revenue faster at -0.8% — sustainability is the question.
GBIO generates stronger free cash flow (-53M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
GBIO scores higher overall (32/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Generation Bio Co
HEALTHCARE · BIOTECHNOLOGY · USA
Generation Bio Co., a genetic drug company, develops gene therapies for the treatment of rare and prevalent diseases. The company is headquartered in Cambridge, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?